Table 2 Group analysis
Total patients 61 | |
|---|---|
Age | Mean: 31 Min–Max: 1–84 |
Sex | M: 33/61—54% |
F: 28/61—47% | |
Main event (reported in 51 patients) | Skull linear fracture: 25/51: 49% |
Orbital roof fracture: 8/51: 15.7% | |
Mild trauma without evident fracture: 7/51: 13.7% | |
Facial bone fracture: 6/51: 11.7% | |
Subdural hematoma: 5/51: 9.8% | |
Intracranial hemorrhage: 2/51: 3.9% | |
Location of direct trauma | Frontal: 19/61 cases—31.1% |
Parieto-occipital 10/61 cases—16.4% | |
Temporal: 32/61 cases—52.45% | |
Timing | Min: 24 h Max: 43 years |
Onset symptoms at diagnosis of ME | Otological symptoms—27/61—44.26% |
CSF leak—10/61—16.4% | |
Ocular symptoms—8/61—13.1% | |
Seizure—3/61—4.9% | |
Neurological deficits—2/61—3.3% | |
Weakness—1/61—1.6% | |
Loss of consciousness 2/61—3.3% | |
Headache—3/61—4.9% | |
Swelling—4/61—6.55% | |
Treatment | Duroplasty—29/50—58% |
Bone reconstruction 8/50—16% | |
Galea flap 6/50—12% | |
Endoscopic repair 8% | |
Observation 3% | |
Complications | 4—6.5% |